ATBECHDEDKESFRGBGRITLILUNLSEMCPTIE..............................................JDIM360 Ver 2.15 (14 Jul 2008) - 2999001/01160256CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120090401W173deBibliographieenBibliographyfrBibliographieEP01114005.0199602142003043020030602enenen38846319950214US2009040120091420011205200149200706272007262007010220090401200914C07K 16/18 20060101AFI20011010BHEP deFür das Beta-A4 (1-42) Peptid spezifischer monoklonaler AntikörperenMonoclonal antibody specific for beta-A4 (1-42) peptidefrAnticorps monoclonal spécifique du peptide beta-A4 (1-42)WO-A-91/16628WO-A-94/17197GREER M. MURPHY ET AL.: "DEVELOPMENT OF A MONOCLONAL ANTIBODY SPECIFIC FOR THE COOH-TERMINAL OF BETA-AMYLOID 1-42 AND ITS IMMUNOHISTOCHEMICAL REACTIVITY IN ALZHEIMER'S DISEASE AND RELATED DISORDERS." AMERICAN JOURNAL OF PATHOLOGY, vol. 144, no. 5, May 1994 (1994-05), pages 1082-1088, XP00057394896906616.608096561996082207012421.9184285920070625Konig, GerhardTannenstrasse 840476 DüsseldorfDEGraham, Paul43 Hubinger StreetNew Haven, CT 06511USWyeth04088651P036095EP:CPMFive Giralda FarmsMadison, New Jersey 07940USElan Pharma International Limited07526660P036095EP:CPMMonkslandAthlone WestmeathIEMercer, Christopher Paulet al00046611Carpmaels & Ransford 43, Bloomsbury SquareLondon WC1A 2RAGB01200803271AstraZeneca AB00183400151 85 SödertäljeSELovell, Catherine Jane09313431AstraZeneca Global Intellectual Property 15 Stanhope GateGB- London W1K 1LNGBATBECHDEDKESFRGBGRIEITLILUMCNLPTSE20021106200245